Loading...

NanoRepro AG

NN6.DEXETRA
HealthcareMedical - Diagnostics & Research
1.37
0.05(3.79%)

NanoRepro AG (NN6.DE) Stock Overview

Explore NanoRepro AG’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for NN6.DEStats details for NN6.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NN6.DEAnalyst Recommendations details for NN6.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.

CEO

Ms. Lisa Jungst

Employees

22

Headquarters

Untergasse 8, Marburg

Founded

2009

Frequently Asked Questions